Breaking News Instant updates and real-time market news.

SITE

SiteOne Landscape

$65.68

-0.535 (-0.81%)

08:13
10/12/18
10/12
08:13
10/12/18
08:13

SiteOne Landscape initiated with a Buy at Jefferies

Jefferies analyst Stephen Volkmann started SiteOne Landscape with a Buy rating and $80 price target. The analyst calls SiteOne his highest-conviction growth story in Distributors. The company remains in the "very early innings of consolidating a "still very fragmented space," Volkmann tells investors in a research note. He sees margin upside via economies of scale, growth with small contractors and private label.

  • 31

    Oct

SITE SiteOne Landscape
$65.68

-0.535 (-0.81%)

10/11/18
10/11/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. GoDaddy (GDDY) upgraded to Buy from Neutral at Citi with analyst Mark May saying he views the recent pullback in the shares as a buying opportunity. 2. Lumentum (LITE) upgraded to Overweight from Neutral at JPMorgan with analyst Samik Chatterjee citing the recent pullback in the shares and a stronger outlook in telecom. 3. Lear (LEA) upgraded to Buy from Neutral at Goldman Sachs with analyst David Tamberrino saying he views the company as a "potential market share winner" with "solid" free cash flow and an "undemanding" valuation. 4. SiteOne Landscape (SITE) upgraded to Neutral from Sell at UBS with analyst Steven Winoker saying the stock now better reflects the company's near-term risks and long-term rollup strategy. 5. WSFS Financial (WSFS) upgraded to Outperform from Market Perform at Keefe Bruyette with analyst Michael Perito saying the pullback in shares since the August Beneficial Bancorp acquisition announcement overlooks the "critical merits of the transaction and the historic track record" of WSFS. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/11/18
UBSW
10/11/18
UPGRADE
Target $75
UBSW
Neutral
SiteOne Landscape upgraded to Neutral from Sell at UBS
UBS analyst Steven Winoker upgraded SiteOne Landscape to Neutral from Sell while lowering his price target for the shares to $75 from $80. The stock, after dropping 25% since peaking in late June, now better reflects the company's near-term risks and long-term rollup strategy, Winoker tells investors in a research note. He says the correction has overshot his estimate of company value and that he sees a more balanced upside/downside at current share levels.
10/11/18
UBSW
10/11/18
UPGRADE
UBSW
Neutral
SiteOne Landscape upgraded to Neutral from Sell at UBS
10/02/18
GSCO
10/02/18
INITIATION
Target $111
GSCO
Buy
SiteOne Landscape initiated with a Buy at Goldman Sachs
Goldman Sachs analyst Doug Clark initiated SiteOne with a Buy and $111 price target telling investors it is a "well-oiled M&A machine with unparalleled mid-teens top line growth. Clark said SiteOne offers a combination of accelerating acquisitions, a newly established network of distribution centers, and a recently launched e-commerce platform.

TODAY'S FREE FLY STORIES

09:45
10/23/18
10/23
09:45
10/23/18
09:45
Hot Stocks
Breaking Hot Stocks news story  »

Bio Rad Laboratories…

TSLA

Tesla

$263.12

2.09 (0.80%)

09:45
10/23/18
10/23
09:45
10/23/18
09:45
Hot Stocks
Citron reverses opinion on Tesla, goes long shares into earnings »

Citron Research, best…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 29

    Oct

  • 13

    Dec

09:45
10/23/18
10/23
09:45
10/23/18
09:45
General news
U.S. Richmond Fed index preview: »

U.S. Richmond Fed index…

09:45
10/23/18
10/23
09:45
10/23/18
09:45
General news
Richmond Fed Manufacturing Index Level to be reported at 10:00 »

October Richmond Fed…

VFC

VF Corp.

$77.62

(0.00%)

09:43
10/23/18
10/23
09:43
10/23/18
09:43
Recommendations
VF Corp. analyst commentary  »

VF Corp price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SMH

Market Vectors Semiconductor

$95.61

(0.00%)

09:42
10/23/18
10/23
09:42
10/23/18
09:42
Technical Analysis
Technical Take: Market Vectors Semiconductor at new 52-week low, major top »

The Market Vectors…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MA

MasterCard

$204.52

(0.00%)

09:40
10/23/18
10/23
09:40
10/23/18
09:40
Options
Unusually active option classes on open October 23rd »

Unusual total active…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

HON

Honeywell

$152.63

-0.86 (-0.56%)

09:39
10/23/18
10/23
09:39
10/23/18
09:39
Upgrade
Honeywell rating change  »

Honeywell upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QTS

QTS Realty Trust

$40.40

-0.59 (-1.44%)

09:39
10/23/18
10/23
09:39
10/23/18
09:39
Upgrade
QTS Realty Trust rating change  »

QTS Realty Trust upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

  • 07

    Nov

EXPI

eXp World Holdings

$12.50

0.35 (2.88%)

09:39
10/23/18
10/23
09:39
10/23/18
09:39
Hot Stocks
eXp Realty to acquire ShowMeNow, terms not disclosed »

eXp Realty, a subsidiary…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

TSLA

Tesla

$261.03

0.97 (0.37%)

09:38
10/23/18
10/23
09:38
10/23/18
09:38
Periodicals
Breaking Periodicals news story on Tesla »

Citron says long Tesla…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 29

    Oct

  • 13

    Dec

KOF

Coca-Cola Femsa

$59.41

-1.75 (-2.86%)

09:36
10/23/18
10/23
09:36
10/23/18
09:36
Upgrade
Coca-Cola Femsa rating change  »

Coca-Cola Femsa upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORCL

Oracle

$47.93

0.34 (0.71%)

09:35
10/23/18
10/23
09:35
10/23/18
09:35
Initiation
Oracle initiated  »

Oracle initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 24

    Oct

  • 25

    Oct

  • 25

    Oct

  • 14

    Nov

09:35
10/23/18
10/23
09:35
10/23/18
09:35
Conference/Events
JPMorgan European & EMEA analysts to hold analyst/industry conference call »

European Utilities…

ABBV

AbbVie

09:35
10/23/18
10/23
09:35
10/23/18
09:35
Initiation
AbbVie initiated  »

AbbVie initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Nov

SNY

Sanofi

09:35
10/23/18
10/23
09:35
10/23/18
09:35
Initiation
Sanofi initiated  »

Sanofi reinitiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 28

    Oct

  • 29

    Oct

  • 28

    Jan

  • 22

    Mar

  • 28

    Apr

RHHBY

Roche

09:35
10/23/18
10/23
09:35
10/23/18
09:35
Initiation
Roche initiated  »

Roche reinitiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

  • 24

    Dec

09:35
10/23/18
10/23
09:35
10/23/18
09:35
General news
Treasury 2-year auction outlook: the $38 B 2-year sale »

Treasury 2-year auction…

PFE

Pfizer

$44.37

-0.13 (-0.29%)

09:34
10/23/18
10/23
09:34
10/23/18
09:34
Initiation
Pfizer initiated  »

Pfizer reinitiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

  • 07

    Nov

GSK

GlaxoSmithKline

09:34
10/23/18
10/23
09:34
10/23/18
09:34
Initiation
GlaxoSmithKline initiated  »

GlaxoSmithKline…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 31

    Oct

  • 07

    Nov

LLY

Eli Lilly

09:34
10/23/18
10/23
09:34
10/23/18
09:34
Initiation
Eli Lilly initiated  »

Eli Lilly reinitiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

  • 07

    Nov

NVS

Novartis

$87.12

-0.07 (-0.08%)

09:34
10/23/18
10/23
09:34
10/23/18
09:34
Initiation
Novartis initiated  »

Novartis reinitiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

MRK

Merck

$72.56

0.22 (0.30%)

09:34
10/23/18
10/23
09:34
10/23/18
09:34
Initiation
Merck initiated  »

Merck reinitiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 25

    Oct

  • 29

    Oct

  • 11

    Jan

  • 16

    Feb

BMY

Bristol-Myers

$50.87

-3.44 (-6.33%)

09:34
10/23/18
10/23
09:34
10/23/18
09:34
Initiation
Bristol-Myers initiated  »

Bristol-Myers reinitiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

  • 29

    Oct

  • 07

    Nov

  • 20

    May

AZN

AstraZeneca

$39.50

0.295 (0.75%)

09:34
10/23/18
10/23
09:34
10/23/18
09:34
Initiation
AstraZeneca initiated  »

AstraZeneca reinitiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 07

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.